Physician profile
Christopher Dubuque
NPI 1639545528
$2,993.37
in general payments reported to CMS, 2019-2025
15 companies · $1,760 in 2025
The $1,760 reported for 2025 was more than what 92% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $490 · 2023: $412 · 2024: $331 · 2025: $1,760.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,387 · Education: $116.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,387.05 |
| Education | $116.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $1,172.87 | 2024-2025 | Apligraf, Cygnus Dual, Simplimax |
| Novo Nordisk INC | $727.45 | 2022-2025 | Ozempic, Rybelsus, Wegovy |
| Bard Peripheral Vascular, INC. | $313.44 | 2025 | Rotarexs 6 F X 135 Cm |
| Abbvie INC. | $272.07 | 2023-2025 | |
| Abbott Laboratories | $110.40 | 2023 | Absolute Pro |
| Solventum Corporation | $81.53 | 2024-2025 | V.A.C. Veraflo, Activ.A.C., V.A.C. Dermatac |
| Amgen INC. | $72.68 | 2023-2025 | Evenity, Prolia |
| Lilly USA, LLC | $48.02 | 2022-2023 | Mounjaro |
| Galderma Laboratories, L.P. | $43.43 | 2024-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $30.55 | 2022 | |
| Ani Pharmaceuticals, INC. | $28.44 | 2025 | Purified Cortrophin Gel |
| Boehringer Ingelheim Pharmaceuticals, INC. | $27.93 | 2022 | |
| Amarin Pharma, INC. | $23.26 | 2023 | |
| Exact Sciences Corporation | $20.72 | 2025 | Cologuard Collection Kit |
| Irhythm Technologies, INC. | $20.58 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Dubuque listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.